Unveiling the Hidden Risks: Stress Echo and Asymptomatic Hypertrophic Cardiomyopathy
Imagine a silent threat lurking within seemingly healthy individuals. Recent research has shed light on a surprising discovery: many adults with hypertrophic cardiomyopathy (HCM) may appear clinically well, but they carry hidden physiological limitations that could pose long-term risks. This revelation challenges our understanding of asymptomatic HCM and prompts a deeper exploration of diagnostic tools and treatment strategies.
A large observational study spanning over a decade has provided valuable insights. By employing treadmill stress echocardiography (TSE), researchers uncovered meaningful diagnostic and prognostic information in adults with asymptomatic HCM. The study, presented at the American Heart Association's 2025 Scientific Sessions and published in the Journal of the American College of Cardiology, revealed that TSE can help identify patients with worse survival outcomes and guide decisions for earlier septal reduction.
But here's where it gets controversial: despite thorough clinical evaluations confirming their asymptomatic status, a significant proportion of adults (37%) showed reduced exercise capacity. This finding suggests that the traditional classification of HCM patients may not capture the full spectrum of disease severity.
And this is the part most people miss: obstructive HCM (oHCM), characterized by a left ventricular outflow tract (LVOT) gradient of 30 mm Hg or more, was prevalent in the study population. These individuals demonstrated more severe underlying disease, including thicker left ventricular walls and increased mitral regurgitation. Consequently, they achieved lower exercise capacity metrics compared to those with nonobstructive HCM (nHCM).
Over a mean follow-up period of nearly 13 years, the study revealed a composite of events, including mortality, ICD shocks, and cardiac transplants. Reduced exercise performance emerged as a critical risk marker, with patients achieving at least 85% of their age- and gender-predicted METs (AGP-METs) exhibiting significantly better survival rates.
Furthermore, the phenotype of HCM played a pivotal role. Patients with nHCM or oHCM who underwent myectomy experienced significantly better long-term freedom from composite events compared to those with oHCM who did not undergo myectomy. This highlights the importance of personalized treatment approaches based on disease characteristics.
The researchers concluded that careful evaluation is essential to identify obstructive physiology and ascertain true asymptomatic status in HCM patients. They emphasized the potential for optimizing the timing of therapeutic interventions, either preemptively or at the onset of early symptoms. However, they acknowledged the need for prospective validation of these observational findings.
Stress echocardiography emerges as a powerful tool in confirming asymptomatic status. By assessing physiological limitations, it helps clinicians determine whether patients are genuinely asymptomatic or if their functional impairment has been overlooked. This study builds upon previous research, demonstrating that persistent LVOT obstruction and progressive cardiomyopathy can remain clinically silent yet pose elevated risks.
TSE's role in this analysis was pivotal, providing incremental diagnostic and prognostic value. It helped delineate obstructive HCM physiology, identify dynamic changes, and inform clinical decisions. While the study's generalizability is limited by its retrospective design and single-center nature, the large cohort and long-term follow-up strengthen the evidence for the influence of exercise capacity and obstructive physiology on outcomes, even in seemingly well patients.
This research opens up a new perspective on asymptomatic HCM, highlighting the importance of comprehensive evaluation and personalized treatment approaches. It invites further discussion and exploration, leaving us with thought-provoking questions: How can we optimize the management of asymptomatic HCM patients? What are the implications of these findings for clinical practice and patient care? Share your thoughts and insights in the comments below!
